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In bullfrog larvae at the pre- and pro-metamorphic stages, feeding behavior is regulated
by appetite factors such as orexigenic peptides. In fact, food intake is enhanced by
intracerebroventricular (ICV) administration of neuropeptide Y (NPY) and orexin A. Using
goldfish, our previous study indicated that the orexigenic action of NPY is mediated
by orexin A, suggesting the functional interaction between the two. However, there is
little information about whether the action of orexin A mediates the orexigenic action
of NPY in bullfrog larvae. Therefore, we examined the effect of the orexin receptor
antagonist, SB334867 on the orexigenic action of NPY in larvae. The stimulatory effect
of ICV injection of NPY at 10 pmol/g body weight (BW) on food intake was abolished
by treatment with SB334867 at 60 pmol/g BW. These results suggest that, in bullfrog
larvae, there is a neuronal relationship between the NPY and orexin systems, and that
the orexigenic action of NPY is mediated by the orexin A-induced orexigenic action.
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INTRODUCTION
Neuropeptide Y (NPY) was first identified from porcine central nervous system. NPY is belonging
NPY family of peptides including peptide YY and pancreatic polypeptide, and it is one of the
most highly conserved neuropeptides in vertebrates and even in invertebrates (Tatemoto et al.,
1982; Blomqvist et al., 1992). NPY occurs abundantly in not only the central, but also peripheral
nervous systems, and is involved in many roles such as cardiovascular control and neuroendocrine
function in mammals (Karl and Herzog, 2007). NPY stimulates feeding behavior, and it has been
considered a potent orectic neuropeptide in the mammalian brain (Woods et al., 1998). Orexin is a
neuropeptide that was first isolated as an orphan receptor ligand, and subsequently identified as an
appetite stimulator (Sakurai et al., 1998). Orexin has two molecular forms, orexin A and B, derived
from the same precursor. In addition to its orexigenic action, orexin regulates energy consumption,
rhythmicity, and neuronal apoptosis (Matsuki and Sakurai, 2008; Shioda et al., 2008).
An understanding of the evolutionary process of the NPY- and orexin-regulated system
of feeding behavior could provide discernment into the physiological role of these functions
throughout the vertebrates. In anuran brains, the neuroanatomical distributions of NPY and
orexin have been described in detail (Danger et al., 1985; Cailliez et al., 1987; Galas et al.,
2001), and primary structures of frog NPY and Xenopus orexin have been determined (Chartrel
et al., 1991; Shibahara et al., 1999). Our previous studies have indicated that, in bullfrog larvae
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at the pre- and pro-metamorphic stages, intracerebroventricular
(ICV) administration of NPY and orexin A enhances food intake,
suggesting that these neuropeptides act as potent orexigenic
factors in the larvae of anuran amphibians (Shimizu et al.,
2013, 2014b). Some previous papers have also documented the
regulation of feeding by NPY and orexin A in fish (Lin et al.,
2000; de Pedro and Bjornsson, 2001; Volkoff and Peter, 2001;
Aldegunde and Mancebo, 2006; Gorissen et al., 2006; Matsuda
and Maruyama, 2007; Xu and Volkoff, 2007; Matsuda, 2009).
Especially, it has been shown that NPY and orexin A act as
representative appetite enhancers in goldfish (López-Pati-o et al.,
1999; Volkoff et al., 1999; Narnaware et al., 2000; Miura et al.,
2006, 2007; Nakamachi et al., 2006). A previous study has also
provided evidence that, in goldfish, NPY-induced appetite is
mediated by orexin A, suggesting that the two peptides share
a functional relationship for regulation of feeding (Volkoff and
Peter, 2001). However, there is little information about the
relationship between NPY and orexin A in the regulation of food
intake in bullfrog larvae. Therefore, to clarify whether orexin
A mediates the orexigenic action of NPY, we investigated the
effect of ICV administration of an orexin receptor antagonist,




Bullfrog (Rana catesbeiana) larvae weighing 5–7 g were collected
from ponds in the suburbs of Toyama City, Japan. The
developmental stages of the larvae were determined according to
Taylor and Kollros (1946). Since the body size of obtained larvae
at premetamorphic stages was very small, experiments were
done using 100 larvae at prometamorphic stages (XI–XIX). As
previously described (Shimizu et al., 2013), the animals were kept
for 1–2 weeks under controlled light/dark conditions (12L/12D)
with the water temperature maintained at 20–24◦C. The larvae
were fed every day at noon with a powder diet (Itosui Co.,
Tokyo, Japan) until used in experiments. Animal experiments
were conducted in accordance with the Invasive Alien Species
Act of Japan and the University of Toyama’s guidelines for the
care and use of alien and laboratory animals, and were done by
approval of an ethics committee of the University of Toyama and
permission of government authorities (No. 05000361).
Chemicals
In order to examine the effects of ICV administration of NPY
and orexin A on food intake, and the effects of NPY receptor
and orexin receptor antagonists on the actions of ICV-injected
NPY and orexin A in prometamorphic larvae, the following
chemicals were used. A NPY Y1-receptor antagonist, BIBP3226
(diphenylacetyl-D-Arg-4-hydroxybenzylamide, Bachem AG,
Bubendorf, Switzerland) and a selective orexin receptor
antagonist, SB334867 [N-(2-methyl-6-benzoxazolyl)-N′-1,5-
naphthyridin-4-yl urea, Tocris Cookson Ltd., Bristol, UK], were
purchased commercially, dissolved in dimethyl sulfoxide at
20–50mM for storage, and diluted with 0.6% NaCl and 0.02%
Na2CO3 solution (saline) before use. NPY (rat NPY, Peptide
Institute Co., Osaka, Japan) and orexin-A (rat orexin-A, Peptide
Institute) were also purchased commercially, dissolved in saline
at 0.1mM for storage at −80◦C, and diluted with saline before
use. 3-Aminobenzoic acid ethyl ester (MS-222) for anesthesia
was obtained commercially from Sigma-Aldrich (St. Louis, MO,
USA), and was prepared at concentration of 0.15%. Each animal
was exposed to this solution for 2min.
Measurement of Food Intake
Details of the methods used for measuring food consumption in
the larvae have been reported elsewhere (Matsuda et al., 2010;
Shimizu et al., 2013, 2014a,b). As previously described (Shimizu
et al., 2014b), two types of powder diet colored green and red,
respectively (containing the same components as those described
above), were obtained from Itosui Co., Tokyo, Japan. First, the
test prometamorphic larvae were fed the green-colored diet and
kept under laboratory conditions. Then, after a 24-h fast, an
adequate amount of the red-colored food was made available at
3% of BW. Test substances were ICV-administered as described
below, and after 15min, each animal was decapitated and the
gastrointestinal tract was removed. In our previous study, we
observed food intake in intact and ICV-injected larvae during
60min after recovery from anesthesia. Then, we determined that
food intake is measured during first 15 min. The wet weight
of the red-colored gastrointestinal contents was measured after
removal of intestinal juice with tissue paper, and expressed as
micrograms of food taken per gram BW. The experiments were
conducted around noon.
Effect of ICV Administration of BIBP3226
and SB334867 on the Orexigenic Actions of
ICV-Injected NPY and Orexin A
In order to double-check the orexigenic actions of NPY and
orexin A, and the antagonistic actions of BIBP3226 and SB334867
upon them (Shimizu et al., 2013, 2014b), we examined the
effects of ICV administration of NPY, orexin A, BIBP3226,
and SB334867 on food intake in prometamorphic larvae. Our
previous studies have indicated that simultaneous injection
of antagonists with peptides induces their antagonistic effects
(Shimizu et al., 2013, 2014b).
We did not have an atlas for bullfrog larval brain. However,
according to our previous experiments, same procedures have
been done. Therefore, following sentences were mainly quoted
from our previous paper (Matsuda et al., 2010; Shimizu et al.,
2013, 2014b). “For ICV administration of test substances, each
animal was placed in a stereotaxic apparatus under anesthesia
with MS-222. A small area (∼1 mm2 square) of the parietal skull
was carefully removed using a surgical blade (No. 19, Futaba,
Tokyo, Japan), and then 0.1 µl/g BW (0.5–0.7 µl) of each test
substance including Evans blue dye was injected into the third
ventricle of the brain using a 10-µl Hamilton syringe with a
0.1-µl scale. The gap in the parietal skull was then filled with
a surgical bonding agent (Aron Alpha, Sankyo, Japan). The
accuracy of the injection site and volume was confirmed after the
experiment by examining whether Evans blue dye was present in
the ventricle without leakage. Control larvae in each experiment
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were injected with the same volume of saline in the same way as
for the experimental group. Each larva that had received the ICV
injection was placed individually in a small experimental tank
(diameter 11 cm) containing 700ml of tap water. After recovery
from anesthesia, each larva was supplied with the red-colored
food equivalent to 3% of its BW. After 15min, the weight of the
intestinal contents was measured as described above.”
“In order to check the effect of ICV injection of BIBP3226
on the orexigenic action of NPY at 10 pmol/g BW, half a
microliter of BIBP3226 at 100 pmol/g BW was injected into
the third ventricle of the brain of larvae as described above.
The ICV-injected dose of BIBP3226 had been determined in
previous experiments (Shimizu et al., 2013). Larvae in the control
group were given injections of the same volume of saline-diluted
dimethyl sulfoxide (vehicle). Following the administration of
BIBP3226 or vehicle, either NPY at 10 pmol/g BW or saline
was delivered by ICV injection. The feeding experiment was
performed according to the procedures described above. In order
to check the effect of ICV injection of SB334867 on the central
actions of orexin A, 0.5 µl of SB334867 at 60 pmol/g BW in
addition to orexin A at 6 pmol/g BW was injected into the third
ventricle of the brain of the larvae. The ICV-injected dose of
SB334867 had been determined by reference to a previous study
(Shimizu et al., 2014b). Larvae in the control group were given an
injection of the same volume of dimethyl sulfoxide diluted with
saline.”
Effect of ICV Administration of SB334867
on the Orexigenic Action of ICV-Injected
NPY
According to our previous experiments, same procedures have
been done. Therefore, following sentences were mainly quoted
from our previous paper (Shimizu et al., 2014b). “In order to
examine the effect of ICV injection of SB334867 on the central
action of NPY, 0.5µl of SB334867 at 60 pmol/g BW in addition to
NPY at 10 pmol/g BW was injected into the third ventricle of the
larval brain. Larvae in the control group were given an injection
of the same volume of dimethyl sulfoxide diluted with saline. The
feeding experiment was performed according to the procedures
described above.”
Data Analysis
According to our previous experiments, same statistical analysis
have been done. Therefore, following sentences were quoted from
our previous paper (Kojima et al., 2009). “All results pertaining to
the effect of receptor antagonists on food intake are expressed as
the mean ± SEM. Statistical analysis was performed using two-
way ANOVA with Bonferroni’s method. Statistical significance
was determined at the 5% level.”
RESULTS
Effect of ICV Injection of BIBP3226 on the
Orexigenic Action of ICV-Injected NPY
ICV administration of NPY at 10 pmol/g BW stimulated
cumulative food intake during the 15-min observation period
FIGURE 1 | Effect of ICV administration of a NPY Y1-receptor
antagonist, BIBP3226, on the orexigenic action of NPY in
prometamorphic larvae. Each column and bar represents the mean and
SEM, respectively, and the numbers in parentheses in the panels indicate the
number of larvae in each group. Significance of differences was evaluated by
two-way ANOVA with Bonferroni’s method. Different superscripts (a and b)
indicate statistical significance (P < 0.05).
in comparison with ICV injection of vehicle or BIBP3226 at
100 pmol/g BW. ICV injection of NPY at 10 pmol/g BW plus
BIBP3226 at 100 pmol/g BW did not affect cumulative food
intake during the 15-min observation period in comparison
with ICV injection of vehicle (Figure 1). Interaction between
treatments with NPY and BIBP3226 was significant by two-way
ANOVA with Bonferroni’s method (F = 5.83 and p= 0.023).
Effect of ICV Injection of SB334867 on the
Orexigenic Actions of ICV-Injected
Orexin A
ICV administration of orexin A at 6 pmol/g BW enhanced
cumulative food intake during the 15-min observation period
in comparison with ICV injection of vehicle or SB334867 at
60 pmol/g BW. ICV injection of orexin A at 6 pmol/g BW
plus SB334867 at 60 pmol/g BW did not affect cumulative
food intake for 15min after feeding in comparison with ICV
injection of vehicle (Figure 2). Interaction between treatments
with SB334867 and orexin A was significant by two-way ANOVA
with Bonferroni’s method (F = 8.05 and p= 0.009).
Effect of ICV Administration of SB334867
on the Orexigenic Action of ICV-Injected
NPY
ICV administration of NPY at 10 pmol/g BW increased
cumulative food intake during the 15-min observation period
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FIGURE 2 | Effect of ICV administration of an orexin receptor
antagonist, SB334867, on the orexigenic action of orexin A in
prometamorphic larvae. Each column and bar represents the mean and
SEM, respectively, and the numbers in parentheses in the panels indicate the
number of larvae in each group. Significance of differences was evaluated by
two-way ANOVA with Bonferroni’s method. Different superscripts (a and b)
indicate statistical significance (P < 0.05).
in comparison with ICV injection of vehicle or SB334867 at
60 pmol/g BW. ICV injection of NPY at 10 pmol/g BW plus
SB334867 at 60 pmol/g BW did not affect cumulative food
intake during the 15-min observation period in comparison
with ICV injection of vehicle (Figure 3). Interaction between
treatments with SB334867 and NPY was significant by two-
way ANOVA with Bonferroni’s method (F = 31.9 and
p= 0.0001).
DISCUSSION
Larvae of anuran amphibians can feed and grow until the
metamorphic climax, because as metamorphosis progresses,
many body parts such as the oral and digestive organs are
reconstructed (Ishizuya-Oka and Shi, 2007; Wright et al., 2011).
Therefore, feeding behavior in anuran larvae seems to be
regulated by appetite and satiety factors during the pre- and
pro-metamorphic periods. In bullfrog larvae, ICV administration
of NPY, orexin A, or ghrelin induces an increase of food
consumption, whereas ICV injection of corticotropin-releasing
factor attenuates food intake (Matsuda et al., 2010; Shimizu
et al., 2013, 2014a,b). These findings suggest that NPY, orexin A,
and ghrelin are implicated in the regulation of feeding behavior
as potent orexigenic neuropeptides in the larval brain. We
obtained larvae at pre- and pro-metamorphic stages. However,
premetamorphic larvae were very small. In the present study, we
used prometamorphic bullfrog larvae, and double-checked the
orexigenic actions of NPY and orexin A, and the antagonistic
effects of BIBP3226 and SB334867 upon them.
FIGURE 3 | Effect of ICV administration of SB334867 on the orexigenic
action of NPY in prometamorphic larvae. Each column and bar represents
the mean and SEM, respectively, and the numbers in parentheses in the panel
indicate the number of larvae in each group. Significance of differences was
evaluated by two-way ANOVA with Bonferroni’s method. Different superscripts
(a and b) indicate statistical significance (P < 0.05).
In the goldfish model, our and other previous studies have
indicated that the orexigenic action of NPY is mediated by the
orexin A signaling pathway (Volkoff and Peter, 2001; Kojima
et al., 2009): NPY-induced action was blocked by treatment
with SB334867, and it was also attenuated by treatment with
an excess amount of orexin A. Using a double-immunostaining
and confocal laser scanning microscopy, neuroanatomical
observation has indicated that neurons with NPY- and orexin-
like immunoreactivities are located in the hypothalamic region,
the nucleus posterioris periventricularis, in close proximity to
each other neuron (Kojima et al., 2009). Accordingly, in this
species, there seems to be a functional relationship between NPY
and orexin A in the regulation of feeding. In the present study, we
indicated for the first time that the action of NPY is blocked by
treatment with SB334867. The results suggest that the orexigenic
action of NPY is mediated via the orexin receptor in bullfrog
larvae as well as in goldfish. Thus, it is likely that NPY and orexin
A exert orexigenic actions in bullfrog larvae. This observation
also supports the role of a functional relationship between NPY
and orexin A in feeding regulation among vertebrates (Yamanaka
et al., 2000; Niimi et al., 2001; Sahu, 2002). Bullfrog larvae can
feed and grow until the metamorphic climax, and orexigenic
factors such as NPY and orexin A seem to stimulate appetite, and
to regulate energy balance of larvae during the developmental
stages (Shimizu et al., 2013, 2014b). The present study suggests
that NPY and orexin A ismutually involved in appetite regulation
during the prometamorphic stages.
In conclusion, our data indicate that, in bullfrog larvae, the
orexigenic action of NPY is mediated by the orexin A-induced
orexigenic action.
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